DK1025082T3 - Hidtil ukendt derivater af vitamin D med cyclopropylringe i sidekæderne, fremgangsmåde og mellemprodukter til deres fremstilling samt deres anvendelse til fremstilling af lægemidler - Google Patents

Hidtil ukendt derivater af vitamin D med cyclopropylringe i sidekæderne, fremgangsmåde og mellemprodukter til deres fremstilling samt deres anvendelse til fremstilling af lægemidler

Info

Publication number: DK1025082T3
Authority: DK; Denmark
Prior art keywords: vitamin; intermediates; drugs; manufacture; preparation
Prior art date: 1997-10-01

Application number

DK98954292T

Other languages

Danish (da)

English (en)

Inventor

Andreas Steinmeyer

Guenter Neef

Gerald Kirsch

Katica Schwarz

Herbert Wiesinger

Martin Haberey

Marianne Faehnrich

Gernot Langer

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-01

Filing date

1998-09-29

Publication date

2003-08-18

1998-09-29 Application filed by Schering Ag filed Critical Schering Ag

2003-08-18 Application granted granted Critical

2003-08-18 Publication of DK1025082T3 publication Critical patent/DK1025082T3/da

Links

238000000034 method Methods 0.000 title abstract 3
150000003710 vitamin D derivatives Chemical class 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title abstract 2
229930003316 Vitamin D Natural products 0.000 title 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000000543 intermediate Substances 0.000 title 1
235000019166 vitamin D Nutrition 0.000 title 1
239000011710 vitamin D Substances 0.000 title 1
229940046008 vitamin d Drugs 0.000 title 1
239000013067 intermediate product Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Mycology (AREA)
Microbiology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)

DK98954292T 1997-10-01 1998-09-29 Hidtil ukendt derivater af vitamin D med cyclopropylringe i sidekæderne, fremgangsmåde og mellemprodukter til deres fremstilling samt deres anvendelse til fremstilling af lægemidler DK1025082T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19744127A DE19744127B4 (de)	1997-10-01	1997-10-01	Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln
PCT/EP1998/006159 WO1999016745A1 (fr)	1997-10-01	1998-09-29	Nouveaux derives de vitamine d comprenant des composes cycliques cyclopropyle dans les chaines laterales, procede et produits intermediaires permettant de les preparer, et leur utilisation pour preparer des medicaments

Publications (1)

Publication Number	Publication Date
DK1025082T3 true DK1025082T3 (da)	2003-08-18

Family

ID=7844754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98954292T DK1025082T3 (da)	1997-10-01	1998-09-29	Hidtil ukendt derivater af vitamin D med cyclopropylringe i sidekæderne, fremgangsmåde og mellemprodukter til deres fremstilling samt deres anvendelse til fremstilling af lægemidler

Country Status (14)

Country	Link
US (3)	US7071344B1 (fr)
EP (1)	EP1025082B1 (fr)
JP (1)	JP2001518462A (fr)
CN (1)	CN1214006C (fr)
AT (1)	ATE238987T1 (fr)
AU (1)	AU750011B2 (fr)
CA (1)	CA2305140A1 (fr)
DE (2)	DE19744127B4 (fr)
DK (1)	DK1025082T3 (fr)
ES (1)	ES2199472T3 (fr)
HU (1)	HUP0002479A3 (fr)
IL (1)	IL135364A (fr)
PT (1)	PT1025082E (fr)
WO (1)	WO1999016745A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090098065A1 (en) *	2000-01-11	2009-04-16	Avikam Harel	Composition and methods for the treatment of skin disorders
JP2002069003A (ja) *	2000-08-23	2002-03-08	Teijin Ltd	ビタミンｄ誘導体を含有する骨吸収抑制剤
US7163933B2 (en)	2002-02-22	2007-01-16	Teijin Limited	Treating agent for Paget's disease of bone
GB0307865D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
DE10317922B4 (de) *	2003-04-17	2009-11-26	Presearch Gmbh	Verwendung eines Kombinationspräparates aus oralem Kontrazeptivum und Calcium/Vitamin D
CN1948283B (zh) *	2005-10-14	2010-12-29	台耀化学股份有限公司	维生素d衍生物的制备方法
US9834512B2 (en)	2011-06-03	2017-12-05	Wisconsin Alumni Research Foundation	(22E)-2-methylene-26,27-cyclo-22-dehydro-1α-hydroxy-19-norvitamin D3 derivatives
GB202016614D0 (en)	2020-10-20	2020-12-02	King S College London	Compounds
CN116173217A (zh) *	2023-02-24	2023-05-30	浙江大学	维生素d受体激动剂在制备治疗运动神经元疾病产品中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07100685B2 (ja)	1985-08-02	1995-11-01	レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ）	新規ビタミンｄ類似体
KR0144358B1 (ko) *	1988-04-21	1998-07-15	피. 라이달 크리스텐슨	비타민 d 동족체
GB8915770D0 (en) *	1989-07-10	1989-08-31	Leo Pharm Prod Ltd	Chemical compounds
DE4220757A1 (de) *	1992-06-24	1994-01-05	Schering Ag	Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4221961A1 (de)	1992-06-30	1994-01-05	Schering Ag	22-En-25-oxa-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, diese Derivate enthaltenen pharmazeutische Präparate sowie deren Verwendung als Arzneimittel
DE4234382A1 (de) *	1992-10-06	1994-04-07	Schering Ag	25-Carbonsäure-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
IL107185A (en)	1992-10-06	1998-02-22	Schering Ag	Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
GB9226860D0 (en) *	1992-12-23	1993-02-17	Leo Pharm Prod Ltd	Novel treatment
DE4445045A1 (de) *	1994-12-08	1996-06-13	Schering Ag	20-Fluor-substituierte Vitamin D-Derivate, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Arzneimitteln und Zwischenprodukte zur Darstellung der Verbindungen
CA2175881A1 (fr) *	1995-05-09	1996-11-10	Andrzej Kutner	Composes de type vitamine d et methodes pour les preparer
ES2144239T3 (es)	1995-06-14	2000-06-01	Schering Ag	Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
DE19619036A1 (de) *	1996-04-30	1997-11-13	Schering Ag	Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln

1997
- 1997-10-01 DE DE19744127A patent/DE19744127B4/de not_active Expired - Fee Related
1998
- 1998-09-28 IL IL13536498A patent/IL135364A/xx not_active IP Right Cessation
- 1998-09-29 ES ES98954292T patent/ES2199472T3/es not_active Expired - Lifetime
- 1998-09-29 US US09/509,934 patent/US7071344B1/en not_active Expired - Fee Related
- 1998-09-29 DK DK98954292T patent/DK1025082T3/da active
- 1998-09-29 AT AT98954292T patent/ATE238987T1/de not_active IP Right Cessation
- 1998-09-29 CN CNB988097834A patent/CN1214006C/zh not_active Expired - Fee Related
- 1998-09-29 EP EP98954292A patent/EP1025082B1/fr not_active Expired - Lifetime
- 1998-09-29 DE DE59808193T patent/DE59808193D1/de not_active Expired - Fee Related
- 1998-09-29 PT PT98954292T patent/PT1025082E/pt unknown
- 1998-09-29 AU AU11476/99A patent/AU750011B2/en not_active Ceased
- 1998-09-29 HU HU0002479A patent/HUP0002479A3/hu unknown
- 1998-09-29 WO PCT/EP1998/006159 patent/WO1999016745A1/fr not_active Ceased
- 1998-09-29 CA CA002305140A patent/CA2305140A1/fr not_active Abandoned
- 1998-09-29 JP JP2000513831A patent/JP2001518462A/ja not_active Withdrawn
2002
- 2002-08-08 US US10/214,166 patent/US20030018194A1/en not_active Abandoned
2005
- 2005-06-01 US US11/141,060 patent/US20050227951A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE19744127B4 (de)	2006-10-05
CA2305140A1 (fr)	1999-04-08
HUP0002479A2 (hu)	2000-12-28
HK1032389A1 (en)	2001-07-20
EP1025082A1 (fr)	2000-08-09
US7071344B1 (en)	2006-07-04
US20050227951A1 (en)	2005-10-13
WO1999016745A1 (fr)	1999-04-08
DE19744127A1 (de)	1999-04-15
CN1272840A (zh)	2000-11-08
EP1025082B1 (fr)	2003-05-02
AU750011B2 (en)	2002-07-11
ATE238987T1 (de)	2003-05-15
PT1025082E (pt)	2003-09-30
IL135364A0 (en)	2001-05-20
HUP0002479A3 (en)	2001-07-30
DE59808193D1 (de)	2003-06-05
US20030018194A1 (en)	2003-01-23
JP2001518462A (ja)	2001-10-16
AU1147699A (en)	1999-04-23
IL135364A (en)	2005-11-20
ES2199472T3 (es)	2004-02-16
CN1214006C (zh)	2005-08-10

Publication	Publication Date	Title
CY1108279T1 (el)	2014-02-12	17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΑ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΑΥΤΩΝ, Η ΧΡΗΣΗ ΤΩΝ 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΩΝ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΜΕΣΩΝ ΚΑΘΩΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΑΡΑΣΚΕΥΑΣΜΑΤΑ
PL376793A1 (pl)	2006-01-09	Spirocykliczne pochodne cykloheksanu
GT199900054A (es)	2000-10-07	Uso de dihidropirimidinas como medicamento y nuevas sustancis. as.
PT1214093E (pt)	2005-04-29	Processo para a preparacao de um produto comprimido a base de isomaltulose, isomaltose e variantes da isomaltose e produtos respectivos
FI980862A0 (fi)	1998-04-17	Kiraalisia metyylifenyylioksatsolidinoneja
NZ515891A (en)	2004-03-26	New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
WO2001010816A3 (fr)	2001-08-23	Derives de 2-dialkylaminoalkylbiphenyle
DK1025082T3 (da)	2003-08-18	Hidtil ukendt derivater af vitamin D med cyclopropylringe i sidekæderne, fremgangsmåde og mellemprodukter til deres fremstilling samt deres anvendelse til fremstilling af lægemidler
MY143958A (en)	2011-07-29	Quinazolinone derivatives and their use as cb agonists
DE59904180D1 (de)	2003-03-06	Cyclopentabenzofuran-derivate und ihre verwendung
YU63696A (sh)	1999-07-28	Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
DK1121364T3 (da)	2003-03-17	Fremgangsmåde til fremstilling af epothilon B og derivater samt mellemprodukter til fremstilling deraf
WO2001002350A3 (fr)	2001-03-29	Nouveaux aminosulfonamides et amidosulfonamides utilises en tant qu'agents antiviraux
DK656588D0 (da)	1988-11-24	Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
NO904576L (no)	1991-04-25	Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
BG105326A (bg)	2001-11-30	Нови бензоилгуанидинови производни с преимуществени свойства, метод за тяхното получаване и тяхнотоприложение при производството на лекарствени средства
DE3768529D1 (de)	1991-04-18	Isohexid-nukleoside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK1246790T3 (da)	2005-08-29	Substituerede 1- og 2-naphthol-Mannichbaser
AR004279A1 (es)	1998-11-04	Procedimientos para preparar 3-(1-piperazinil)-1,2-benzoisotiazol
PL367981A1 (en)	2005-03-21	A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
PT969833E (pt)	2003-10-31	Prolongamento da expressao de proteinas trangenicas atraves de tratamento imunomodulador com 15-deoxispergualina
ATE103899T1 (de)	1994-04-15	Zwischenprodukte und verfahren zu ihrer herstellung.
ATE252566T1 (de)	2003-11-15	Herstellung von 2-(2-arylmorpholin-2- yl)ethanolderivaten und zwischenprodukte
MXPA04001856A (es)	2004-06-15	Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
PT1444244E (pt)	2005-10-31	Processo para a preparacao de desclaritromicina, assim como produtos intermedios